Radiotherapy Side Effect Clinical Trial
Official title:
Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study
The radiotherapy scheme with extreme hypofractionation has gained space in clinical practice and, therefore, it is necessary to analyze the Brazilian national experience in selected patients with breast cancer, with the aim of evaluating the oncological outcomes and toxicities with the use of this treatment protocol.
All patients diagnosed with breast cancer who meet the eligibility criteria at participating centers will be included. Data will be collected from medical records at selected centers. Data collection will start from the location activation date. Data from up to 500 patients are expected to be collected at centers across Brazil. Patients recruited for this study will be identified at participating centers. Data on clinical, demographic and socioeconomic variables will be collected, as well as data on treatments performed and outcomes. The patient data sources will be the patients' medical records. Patients will continue to receive treatment and clinical evaluations for their illness as determined by their medical team, in accordance with the standards of care and usual clinical practice at each center. No intervention is proposed in this study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04059809 -
Photobiomodulation for Breast Cancer Radiodermatitis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05543239 -
Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation on Radiotherapy-Related Neuropathic Pain
|
N/A | |
| Terminated |
NCT04535908 -
Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.
|
N/A | |
| Recruiting |
NCT04115267 -
Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies
|
||
| Recruiting |
NCT05820633 -
Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.
|
N/A | |
| Completed |
NCT05880446 -
PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)
|
N/A | |
| Recruiting |
NCT05724004 -
Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)
|
N/A | |
| Recruiting |
NCT04612907 -
Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer
|
N/A | |
| Recruiting |
NCT05762900 -
Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
|
Phase 2 | |
| Recruiting |
NCT03613506 -
The Role and Intervention of TGF-β in Abdominal Radiation Injury
|
Phase 2 | |
| Completed |
NCT06353724 -
Comparison Between the Effect of Using Conventional and Digital Oral Positional Radiation Stent
|
N/A | |
| Not yet recruiting |
NCT05548504 -
Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
|
Phase 2 | |
| Recruiting |
NCT05224297 -
Patient Experience Data in Radiation Oncology
|
||
| Completed |
NCT04842409 -
Safety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving Surgery
|
||
| Recruiting |
NCT03742687 -
Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
|
N/A | |
| Not yet recruiting |
NCT05614700 -
Prostate Reirradiation Toxicity Outcomes Feasibility Study
|
N/A | |
| Completed |
NCT04027543 -
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）
|
||
| Recruiting |
NCT05354596 -
A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).
|
N/A | |
| Recruiting |
NCT03378856 -
Evaluation of Technological Innovation in Radiotherapy
|
||
| Recruiting |
NCT03343236 -
Nutrition and Inflammation in Patients With Head and Neck Cancer
|